These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14963667)

  • 41. Natriuretic peptides in ectopic myocardial tissues originating from mouse embryonic stem cells.
    Johkura K; Cui L; Yue F; Nitta K; Takei S; Okouchi Y; Asanuma K; Ogiwara N; Sasaki K
    Microsc Res Tech; 2005 Mar; 66(4):165-72. PubMed ID: 15889430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure.
    Del Ry S; Cabiati M; Lionetti V; Simioniuc A; Caselli C; Prescimone T; Emdin M; Giannessi D
    Peptides; 2009 Sep; 30(9):1710-3. PubMed ID: 19540894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptor binding occurrence and plasma levels of natriuretic peptides in response to sympathectomy.
    Hansson M
    Microsc Res Tech; 2005 Jun; 67(2):90-9. PubMed ID: 16037981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ventricular endocrine and mechanical function following thrombolysis for acute myocardial infarction.
    Ramzy IS; Daly CA; O'Sullivan CA; Lam YY; Kemp M; Hooper J; Dancy M; Henein MY
    Int J Cardiol; 2007 Apr; 117(1):51-8. PubMed ID: 17157397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.
    Wiviott SD; de Lemos JA; Morrow DA
    Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor.
    Johns DG; Ao Z; Heidrich BJ; Hunsberger GE; Graham T; Payne L; Elshourbagy N; Lu Q; Aiyar N; Douglas SA
    Biochem Biophys Res Commun; 2007 Jun; 358(1):145-9. PubMed ID: 17475216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium.
    Lax CJ; Domenighetti AA; Pavia JM; Di Nicolantonio R; Curl CL; Morris MJ; Delbridge LM
    Clin Exp Pharmacol Physiol; 2004 Aug; 31(8):512-7. PubMed ID: 15298543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different therapeutic responses to treadmill exercise of heart failure due to ischemia and infarction in rats.
    Yoshinari K; Yaoita H; Maehara K; Maruyama Y
    Cardiovasc Res; 2005 Feb; 65(2):457-68. PubMed ID: 15639485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of C-reactive protein in ischemia/reperfusion injury and preconditioning in a rat model of myocardial infarction.
    Valtchanova-Matchouganska A; Gondwe M; Nadar A
    Life Sci; 2004 Jul; 75(8):901-10. PubMed ID: 15193950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
    Kögler H; Schott P; Toischer K; Milting H; Van PN; Kohlhaas M; Grebe C; Kassner A; Domeier E; Teucher N; Seidler T; Knöll R; Maier LS; El-Banayosy A; Körfer R; Hasenfuss G
    Circulation; 2006 Jun; 113(23):2724-32. PubMed ID: 16754798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury.
    Banz Y; Hess OM; Robson SC; Mettler D; Meier P; Haeberli A; Csizmadia E; Korchagina EY; Bovin NV; Rieben R
    Eur Heart J; 2005 Nov; 26(21):2334-43. PubMed ID: 16055495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review.
    Woods RL
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):791-4. PubMed ID: 15566395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Role of Natriuretic Peptides in the Regulation of Cardiac Tolerance to Ischemia/Reperfusion and Postinfarction Heart Remodeling.
    Krylatov AV; Tsibulnikov SY; Mukhomedzyanov AV; Boshchenko AA; Goldberg VE; Jaggi AS; Erben RG; Maslov LN
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):131-148. PubMed ID: 32840121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interplay between chromogranin A-derived peptides and cardiac natriuretic peptides in cardioprotection against catecholamine-evoked stress.
    Mazza R; Imbrogno S; Tota B
    Regul Pept; 2010 Nov; 165(1):86-94. PubMed ID: 20594992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental investigations in prolonged myocardial ischaemia. Note I. Biology of the myocardial fiber after transient myocardial fiber after transient myocardial ischaemia.
    Laky D; Constantinescu S; Filipescu G; Constantinescu NM; Ratea E; Hâlâlâu F
    Morphol Embryol (Bucur); 1980; 26(2):173-7. PubMed ID: 6446035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental investigations in prolonged myocardial ischaemia. Note II. Biology of the myocardial fiber during permanent ischaemia.
    Laky D; Constantinescu S; Filipescu G; Ratea E; Constantinescu NM; Hălălău F
    Morphol Embryol (Bucur); 1980; 26(4):365-70. PubMed ID: 6450888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Respiratory chain signalling is essential for adaptive remodelling following cardiac ischaemia.
    Szibor M; Schreckenberg R; Gizatullina Z; Dufour E; Wiesnet M; Dhandapani PK; Debska-Vielhaber G; Heidler J; Wittig I; Nyman TA; Gärtner U; Hall AR; Pell V; Viscomi C; Krieg T; Murphy MP; Braun T; Gellerich FN; Schlüter KD; Jacobs HT
    J Cell Mol Med; 2020 Mar; 24(6):3534-3548. PubMed ID: 32040259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thyroid hormone as a therapeutic option for treating ischaemic heart disease: from early reperfusion to late remodelling.
    Pantos C; Mourouzis I; Cokkinos DV
    Vascul Pharmacol; 2010; 52(3-4):157-65. PubMed ID: 19951746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.